Characterization of prostate cancer detected at repeat biopsy

BMC Urology

Volumn 8, Issue 1, 2008, Pages

  Yuasa, Takeshi ^a   Tsuchiya, Norihiko ^a   Kumazawa, Teruaki ^a   Inoue, Takamitsu ^a   Narita, Shintaro ^a   Saito, Mitsuru ^a   Horikawa, Yohei ^a   Satoh, Shigeru ^a   Habuchi, Tomonori ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; MALE; NEEDLE BIOPSY; PATHOLOGY; PROSTATE TUMOR; RETROSPECTIVE STUDY; STATISTICS;

AGED; BIOPSY, NEEDLE; HUMANS; MALE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 58149103570     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-8-14     Document Type: Article

References (15)

1. Determining variables for repeat prostate biopsy. JE Busby CP Evans, Prostate Cancer Prostatic Dis 2004 7 93 8 10.1038/sj.pcan.4500708 14993898
2. Clinicopathological features of prostate cancer in Japanese men diagnosed on repeat transrectal ultrasound-guided biopsy. H Miyake I Sakai K Harada I Hara H Eto, Int J Clin Oncol 2005 10 30 4 10.1007/s10147-004-0448-7 15729598
3. Prostate cancer diagnosed at repeat biopsies have a favorable pathological outcome but similar recurrence rate. E Lopez-Corona M Ohori TM Wheeler VE Reuter PT Scardino MW Kattan JA Eastham, J Urol 2006 175 923 7 16469581 10.1016/S0022-5347(05)00350-2
4. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. SJ Freedland GS Csathy F Dorey WJ Aronson, J Urol 2002 167 516 20 10.1016/S0022-5347(01)69076-1 11792909
5. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms. KJ Gancarczyk H Wu DG McLeod C Kane L Kusuda R Lance J Herring J Foley D Baldwin JT Bishoff D Soderdahl JW Moul, Urology 2003 61 589 95 10.1016/S0090-4295(02)02287-2 12639653
6. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. SJ Freedland GS Csathy F Dorey WJ Aronson, J Urol 2002 167 516 20 10.1016/S0022-5347(01)69076-1 11792909
7. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan. A Yokomizo M Murai S Baba O Ogawa T Tsukamoto M Niwakawa K Tobisu N Kinukawa S Naito, BJU Int 2006 98 549 53 10.1111/j.1464-410X.2006.06379.x 16925752
8. From Prsotate. International Union against Cancer, TNM classification of malignant tumors New York: Wiley-Liss, Sobin LH, Wittekind C, 6 2002 184 7
9. From Histological grading and clinical staging of prostate carcinoma. DF Gleason, Urologic pathology Philadelphia: Lea & Feiger, Tannenbaum M, 1977 171 97
10. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. MS Cookson G Aus AL Burnett ED Canby-Hagino AV D'Amico RR Dmochowski DT Eton JD Forman SL Goldenberg J Hernandez CS Higano SR Kraus JW Moul C Tangen JB Thrasher I Thompson, J Urol 2007 177 540 5 10.1016/j.juro.2006.10.097 17222629
11. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. PG Borboroglu SW Comer RH Riffenburgh CL Amling, J Urol 2000 163 158 62 10.1016/S0022-5347(05)67994-3 10604336
12. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. B Djavan A Zlotta M Remzi K Ghawidel A Basharkhah CC Schulman M Marberger, J Urol 2000 163 1144 8 10.1016/S0022- 5347(05)67711-7 10737484
13. The presence of atypical small acinar proliferation in prostate needle biopsy is predictive of carcinoma on subsequent biopsy. RC Ouyang DN Kenwright JN Nacey B Delahunt, BJU Int 2001 87 70 4 10.1046/j.1464-410x.2001.00989.x 11201402
14. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy. SJ Park H Miyake I Hara H Eto, Int J Urol 2003 10 68 71 10.1046/j.1442-2042.2003.00579.x 12588600
15. Clinical and pathologic features of prostate cancer detected after repeat false-negative biopsy in a screening population. H Steiner P Moser M Hager AP Berger H Klocker R Spranger H Rogatsch G Bartsch W Horninger, Prostate 2004 58 277 82 10.1002/pros.10330 14743467